ReviewTuberculosis and respiratory diseases2017
Asthma-COPD Overlap Syndrome: What We Know and What We Don't.
Review in Tuberculosis and respiratory diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 32 citations in OpenAlex.
- Asthma and chronic obstructive disease overlap (ACO), a systematic review of prevalence and co-morbidity factors based on diagnostic criteria.Journal of pharmaceutical policy and practice · 2026Review
- Histopathological Type of Lung Cancer and Underlying Driver Mutations in Patients with Chronic Obstructive Pulmonary Disease (COPD) versus Patients with Asthma and COPD Overlap: A Single-Center Retrospective Study.Turkish thoracic journal · 2020Article
- Validated methods to identify patients with asthma-COPD overlap in healthcare databases: a systematic review protocol.BMJ open · 2019Article
- Evaluation of the Characteristics of Asthma in Severe and Extremely Severe COPD.International journal of chronic obstructive pulmonary disease · 2019Article
- Eicosanoids metabolized through LOX distinguish asthma-COPD overlap from COPD by metabolomics study.International journal of chronic obstructive pulmonary disease · 2019Article
- Journal Club - Asthma/Chronic Obstructive Pulmonary Disease Overlap: Fact or Fiction?Chronic obstructive pulmonary diseases (Miami, Fla.) · 2018Article
- Disability, quality of life and all-cause mortality in older Mexican adults: association with multimorbidity and frailty.BMC geriatrics · 2018Article
- Increased Risk of Exacerbation in Asthma Predominant Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome.Tuberculosis and respiratory diseases · 2018Article
- Observational
- Neutrophil gelatinase-associated lipocalin as a complementary biomarker for the asthma-chronic obstructive pulmonary disease overlap.Journal of thoracic disease · 2018Article
- Perceptions of Severe Asthma and Asthma-COPD Overlap Syndrome Among Specialists: A Questionnaire Survey.Allergy, asthma & immunology research · 2018Article
- Exhaled Nitric Oxide and Exhaled Breath Temperature as Potential Biomarkers in Patients with Pulmonary Hypertension.BioMed research international · 2018Observational
- Is Osteoporosis a Common Comorbidity in Different Chronic Airway Diseases?Tuberculosis and respiratory diseases · 2018Article
- Heterogeneity of asthma and COPD overlap.International journal of chronic obstructive pulmonary diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Approximately one in four patients with chronic obstructive pulmonary disease (COPD) have asthmatic features consisting of wheezing, airway hyper-responsiveness or atopy. The Global initiative for Asthma/Globalinitiative for chronic Obstructive Lung Disease committee recently labelled these patients as having asthma-COPD overlap syndrome or ACOS. ACOS also encompasses patients with asthma, ≥40 years of age, who have been cigarette smokers (more than 5-10 pack years) or have had significant biomass exposure, and demonstrate persistent airflow limitation defined as a post-bronchodilator forced expiratory volume in 1 second (FEV
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.